交易中 07-14 11:44:26 美东时间
-0.025
-0.14%
并购集体诉讼律师事务所Monteverde & Associates PC宣布,正对四起上市公司并购交易发起股东权益调查,涉及Pulmatrix、...
07-11 03:53
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Delta Air Lines Inc. (NYSE:DAL) to post quarterly earnings of $1.48 per share on revenue of $17.52 billion before the opening bell, according to dat...
07-10 14:39
Simulations Plus ( ($SLP) ) has shared an announcement. On July 9, 2026, Simula...
07-10 04:33
Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.13 by 130.77 percent. This is a 33.33 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $21.886 million...
07-10 04:06
Major earnings expected after the bell on Thursday include: Simulations Plus (SLP) WD-40 Company (WDFC) For Seeking Alpha's full earnings season calendar, click here. More on SA Quant Top 10 Mid-Year ...
07-09 22:00
Companies Reporting Before The Bell • Simply Good Foods (NASDAQ:SMPL) is likely to report quarterly earnings at $0.35 per share on revenue of $332.35 million. • PepsiCo (NASDAQ:PEP) is likely to report quarterly earnings at $2.21 per share on revenue of $23.94 billion. • Northern Technologies (NASDA...
07-09 19:11
William Blair analyst Max Smock downgrades Simulations Plus (NASDAQ:SLP) from Outperform to Market Perform.
06-17 20:40
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Simulations Plus Inc (NASDAQ:SLP) rose sharply as the company agreed to be acquired by Altaris for approximately $375 million. Simulations Plus shares jumped 12.4% to $18.40 on Tuesday. Here are some ot...
06-16 22:08
Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the launch of a
05-06 19:56
Certara stock rises after $135 million divestiture to Veristat as analysts weigh MIDD focus and improving biopharma demand.
04-23 03:23